-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

A New Treatment Strategy in cGVHD

Sponsor: Incyte Corporation
Program: Product Theaters
Hematology Disease Topics & Pathways:
Treatment Considerations, Biological therapies
Saturday, December 7, 2024: 11:30 AM-12:30 PM
Room 5A (San Diego Convention Center)
Speaker:
John Galvin, MD, MPH, Incyte Corporation
Disclosures:
No relevant conflicts of interest to declare.

For in-person participants only
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>